Clinical Trial Update: Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 clinical trial testing topical and oral melatonin to prevent radiochemotherapy-induced oral mucositis and xerostom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Khon Kaen University | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED